Physician

Alan Moreno, MD

According to 2025 Medicare claims, Alan Moreno, MD (NPI: 1427468651) practices nephrology in the Oshkosh-Neenah, WI market, with the plurality of this provider's patient population coming from Winnebago, WI. This provider's primary affiliated billing organization is AURORA MEDICAL GROUP, INC. (NPI: 1427271378; TIN: 391678306) and primary practice location at 54904-7668. Moreno is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), THEDACARE ACO (ACO ID: A4988), and Accountable Care Organization of Advocate Aurora Health, LLC (ACO ID: D0260), participating under both the MSSP and REACH models.

Moreno's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 184 traditional Medicare patients, billed 2,605 HCPCS/CPT codes, and received $84,911 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,727 prescription claims across 369 beneficiaries totaling $322,866 in drug costs, led by Veltassa (Patiromer Calcium Sorbitex). DME data shows 108 claims. Open Payments data shows 3 records totaling $191. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $107,070 to $84,911. In contrast, Part D prescription costs have moved sharply higher in recent years, from $4,741 to $322,866. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$163K$327K2019 Medicare payment: $107,070 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $326,568 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $141,528 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $95,209 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $85,083 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $84,911 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20193211,368$107,070
20206275,094$326,568
20214041,801$141,528
2022220878$95,209
20231911,634$85,083
20241842,605$84,911

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$161K$323K2015 Drug cost: $4,741 (USD; Tot_Drug_Cst)2016 Drug cost: $8,038 (USD; Tot_Drug_Cst)2017 Drug cost: $8,524 (USD; Tot_Drug_Cst)2019 Drug cost: $9,040 (USD; Tot_Drug_Cst)2020 Drug cost: $145,214 (USD; Tot_Drug_Cst)2021 Drug cost: $208,069 (USD; Tot_Drug_Cst)2022 Drug cost: $261,640 (USD; Tot_Drug_Cst)2023 Drug cost: $315,636 (USD; Tot_Drug_Cst)2024 Drug cost: $322,866 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152369$4,741
201618149$8,038
201731119$8,524
2018N/RN/RN/R
20194077$9,040
2020153611$145,214
2021247973$208,069
20222991,844$261,640
20233382,492$315,636
20243692,727$322,866

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.6K$3.3K2021 Medicare payment: $3,263 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $571 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,339 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R52$3,263
2022N/RN/RN/R
2023N/R35$571
2024N/R108$1,339

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more2424$138
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more111196$124
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes2430$118
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes32132$86
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's7298$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VeltassaPatiromer Calcium Sorbitex633,071$83,023
JardianceEmpagliflozin564,180$75,253
EntrestoSacubitril/Valsartan16824$14,832
Potassium Citrate ErPotassium Citrate735,739$13,057
ProsolParenteral Amino Acid 20% No.161428$9,467

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R35$439
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R20$358
J7507Tacrolimus, immediate release, oral, 1 mgNN/R24$338
J7517Mycophenolate mofetil, oral, 250 mgNN/R13$191
J7512Prednisone, immediate release or delayed release, oral, 1 mgNN/R16$14

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$191ABIOMED
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alan Moreno, MD?

Tedicare shows public-source Medicare data for Alan Moreno, MD (NPI 1427468651), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Moreno, MD have ACO affiliation data?

Alan Moreno, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033), THEDACARE ACO (MSSP, ACO ID A4988), and Accountable Care Organization of Advocate Aurora Health, LLC (REACH, ACO ID D0260).

What billing organization is linked to Alan Moreno, MD?

Alan Moreno, MD is linked to AURORA MEDICAL GROUP, INC. (billing NPI 1427271378) in the available physician profile data.

Does Alan Moreno, MD have Open Payments data?

Alan Moreno, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.